跳转至内容
Merck
CN

GF55106580

wire reel, 200m, diameter 1.0mm, as drawn, 99.95+%

别名:

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
Al
CAS号:
分子量:
26.98
MDL编号:
UNSPSC代码:
12141702
PubChem化学物质编号:
NACRES:
NA.23

方案

99.95%

表单

wire

自燃温度

1400 °F

制造商/商品名称

Goodfellow 551-065-80

电阻率

2.6548 μΩ-cm

长度 × 直径

200 m × 1.0 mm

沸点

2460 °C (lit.)

mp

660.37 °C (lit.)

密度

2.7 g/mL at 25 °C (lit.)

SMILES字符串

[Al]

InChI

1S/Al

InChI key

XAGFODPZIPBFFR-UHFFFAOYSA-N

一般描述

For updated SDS information please visit www.goodfellow.com.

法律信息

Product of Goodfellow

储存分类代码

13 - Non Combustible Solids

WGK

WGK 3

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

从最新的版本中选择一种:

分析证书(COA)

Lot/Batch Number

抱歉,我们目前尚未线上提供该产品的COA。

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Christopher Auger et al.
Biotechnology advances, 31(2), 266-273 (2012-12-04)
As our reliance on aluminum (Al) increases, so too does its presence in the environment and living systems. Although generally recognized as safe, its interactions with most living systems have been nefarious. This review presents an overview of the noxious
Joseph Lemire et al.
Journal of inorganic biochemistry, 105(11), 1513-1517 (2011-11-22)
Aluminum (Al) has been implicated in a variety of neurological diseases. However, the molecular mechanisms that enable Al to be involved in these disorders have yet to be fully delineated. Using astrocytes as a model of the cerebral cellular system
J R Walton
Journal of Alzheimer's disease : JAD, 35(1), 7-43 (2013-02-06)
The neuroanatomic specificity with which Alzheimer's disease (AD) progresses could provide clues to AD etiopathology. Magnetic resonance imaging studies of AD clinical progression have confirmed general conclusions from earlier studies of AD neuropathological progression wherein neurofibrillary tangle pathology was observed
C A Shaw et al.
Immunologic research, 56(2-3), 304-316 (2013-04-24)
We have examined the neurotoxicity of aluminum in humans and animals under various conditions, following different routes of administration, and provide an overview of the various associated disease states. The literature demonstrates clearly negative impacts of aluminum on the nervous
Maire E Percy et al.
Journal of inorganic biochemistry, 105(11), 1505-1512 (2011-11-22)
In 1991, treatment with low dose intramuscular desferrioxamine (DFO), a trivalent chelator that can remove excessive iron and/or aluminum from the body, was reported to slow the progression of Alzheimer's disease (AD) by a factor of two. Twenty years later

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门